Cardiovascular disease in Latin America: the growing epidemic

Lanas Fernando1, Serón Pamela1, Lanas Alejandra2

  • 1Universidad de La Frontera, Facultad de Medicina, Temuco, Chile.

Insights

Cardiovascular diseases (CVD) are the leading cause of death in Latin America, causing nearly a million deaths annually. This trend is driven by demographic shifts and increased atherosclerosis risk factors, necessitating urgent public health interventions.

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiology

Background:

  • Cardiovascular diseases (CVD) are the primary cause of mortality in Latin America, accounting for nearly one million deaths annually.
  • A significant increase in CVD-related deaths is projected for the region in the coming years.
  • This epidemiological shift is linked to demographic, economic, and social transformations in Latin America.

Purpose of the Study:

  • To analyze the current burden and trends of cardiovascular diseases in Latin America.
  • To identify the primary drivers of the increasing CVD mortality in the region.
  • To highlight the changing landscape of CVD, with a focus on coronary heart disease and stroke.

Main Methods:

  • Analysis of mortality data for cardiovascular diseases in Latin America.
  • Epidemiological assessment of disease burden and trends.
  • Identification of socioeconomic and lifestyle factors influencing CVD prevalence.

Main Results:

  • Coronary heart disease and stroke are the leading causes of CVD mortality, responsible for 42.5% and 28.8% respectively.
  • Chagas heart disease and rheumatic heart disease now contribute only 1% each to CVD mortality.
  • Improvements in socioeconomic status, increased life expectancy, and a high prevalence of atherosclerosis risk factors are key determinants.

Conclusions:

  • Cardiovascular diseases represent a major and growing public health challenge in Latin America.
  • The epidemiological profile of CVD has shifted, with ischemic heart disease and stroke becoming dominant.
  • Addressing socioeconomic factors and atherosclerosis risk is crucial for mitigating the CVD epidemic in Latin America.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.7K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
598
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
814
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812